theanine 2
TRANSCRIPT
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 1/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
High-Speed Amino Acid Analysis (AAA) on 1.8µmReversed-phase (RP) Columns
Squeezing More into Less
Cliff Woodward1, John Henderson1 and Todd Wielgos2
1Agilent Technologies and 2Baxter Healthcare
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 2/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Introduction: Can we Squeeze More into Less?
Current State:
1. Derivatization and analysis are totally automated2. Cycle time approximately 35 minutes3. Peak shapes of early eluters Asp and Glu relatively
broad4. Reproducibility of secondary AAs less than other AAs5. Linearity by linear regression is almost 1.06. Average area reproducibility is below 3%7. Scalability is limited (3.0 or 4.6mm id)
8. Number of usable columns is limited (4); number ofphases is 1
?
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 3/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
o- Phthalaldehyde (OPA) and 9-Fluorenylmethyl
chloroformate (FMOC) Reactions with Amines
RR’NH
+ orRNH2
Fluorescence: Ex 266nm, Em 305nmDAD: 262, 16nm; Ref. 324,8nm
+RNH2
- HCl
Room Temperature
+ R’SH
Room Temperature
Fluorescence: Ex 230nm, Em 450nmDAD: 338, 10nm; Ref. 390, 20nm
Absorbs at 230nm and 338nm
H
H
O
O
NR
SR
Non-fluorescent, absorbs at 230nm
Does not absorb at 338nm
FluorescentAbsorbs at 266nm andFluoresces at 305nm
OPA
FMOC
’
NRR’
orNHR
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 4/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Amino Acid Analysis (AAA) on RRHT Eclipse Plus C18, 4.6x 50mm, 1.8µ Column: DAD 125pMole on column
min1 2 3 4 5 6
7
*Degradation peaks from reagents
Primary AAs (OPA) Secondary AAs (FMOC)
FMOC and by-products→
1
2
3
4
5
6
8 9 1011
12
1314
15
16
17 1819
22
23
20
21
*
*
*
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 5/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Names and Order of Elution for OPA and FMOCDerivatives of Amino Acids
FMOCPROProline23
FMOCSARSarcosine*22
FMOCHYPHydroxyproline21
OPALYSLysine20
OPALEULeucine19OPAILEIsoleucine18
OPAPHEPhenylalanine17
OPATRPTryptophan16
OPANVANorvaline*15
OPAMETMethionine14
OPAVALValine13
OPACYS-CYSCystine12
OPATYRTyrosine11
OPAALAAlanine10
OPAARGArginine9
OPATHRThreonine8
OPAGLYGlycine7
OPAHISHistidine6
OPAGLNGlutamine5
OPASERSerine4
OPAASNAsparagine3
OPAGLUGlutamic Acid2
OPAASPAspartic Acid1
Derivative TypeAA AbbreviationAA NamePeak #
* Internal Standard
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 6/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Scalability of AAA on various RRHT Eclipse PlusC18, 50mm long, 1.8µ Columns, DAD
mi0 1 2 3 4 5 6 7
mAU
0
10
20
30
40
50
4.6 mm I.D.
3.0 mm I.D.
2.1 mm I.D.
125 pMoles on column
12
3
45
68 9 10 11
1314
15
1617
18 19
22
23
20
217
12
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 7/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Scalability of AAA on various RRHT Eclipse PlusC18, 50mm long, 1.8µ Columns, FLD
4.6 mm I.D.
3.0 mm I.D.
2.1 mm I.D.
min0 1 2 3 4 5 6 7
LU
0
100
200
300
400
500
600
700
800
12
34 56 8
910
1113
14
15
1617
1819
22
232021
7
50 pMoles on column
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 8/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Quantitative Reproducibility using RRHT EclipsePlus C18, 2.1x50mm, 1.8µ Columns
ProlineSarcosineHydroxyprolineLysineLeucineIsoleucine
PhenylalanineTryptophanNorvalineMethionineValineCystineTyrosineAlanineArginineThreonineGlycineHistidine
GlutamineSerineAsparagineGlutamic acidAspartic acid
2.22.31.70.80.71.5
0.91.12.30.80.91.1
11.31.90.91.42.1
2.1*1
1.6†2.30.8
RSD (n=12)
DAD
3.01.91.84.42.10.9
11.33.32.71.5NA
10.9
11.2
10.8
2.9*0.91†0.81.1
RSD (n=10)
FLD
50pMole FLD; 125pMole DAD; Raw Data Areas
Detector Reproducibility
PROSARHPALYSLEUILE
PHETRPNVAMETVALCYS-CYSTYRALAARGTHRGLYHIS
GLN*SERASN†GLUASP
AbbreviationAA Name
†Asparagine is somewhat unstable in solution * Glutamine is very unstable in solution
Average RSD = 1.7 1.4
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 9/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Linearity of AAA on RRHT Eclipse Plus C18, 2.1 x 50mm, 1.8µusing an Agilent 1200SL HPLC System, no Internal Standard
† Asparagine is somewhat unstable in solution* Glutamine is very unstable in solution
0.99690.9981PRO
0.99600.9975SAR
0.99240.9980HYP
0.99570.9857LYS
0.99940.9944LEU 0.99930.9934ILE
0.99960.9925PHE
0.99870.9923TRP
0.99910.9989NVA
0.99970.9944MET
0.99980.9952VAL
NA0.9818CYS-CYS
0.99970.9936TYR
0.99960.9965ALA
0.99980.9960ARG
0.99960.9942THR0.99960.9931GLY
0.99960.9951HIS
0.9937*0.9966*GLN*
0.99970.9933SER
1.0000†0.9928†ASN†
0.99950.9976GLU
0.99920.9949ASP
Coefficients of Linearity (r2)Coefficients of Linearity (r2)Amino Acid
FLDDAD
Using Raw Data Areas
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 10/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Linearity of AAA on RRHT Eclipse Plus C18, 4.6 x 50mm, 1.8µ using anAgilent 1200SL HPLC System with Internal Standards
† Asparagine is somewhat unstable in solution* Glutamine is very unstable in solution
+ I.S. at 250pMole on column for DAD and25pMole on column for FLD
0.999790.99998PRO
I.S.+I.S.+SAR0.997510.99991HYP
0.999790.99956LYS
0.999320.99986LEU
0.999100.99973ILE
0.999430.99988PHE0.996870.99997TRP
I.S.+I.S.+NVA
0.999960.99992MET
0.998860.99992VALNA0.99992CYS-CYS
0.999460.99991TYR
0.999240.99984ALA0.999460.99993ARG
0.999410.99996THR0.996810.99982GLY0.999930.99978HIS
0.99549*0.99996*GLN*
0.998800.99982SER
0.99581†1.00000†ASN†
0.998790.99916GLU0.998870.99995ASP
Coefficients of Linearity (r2)Coefficients of Linearity (r2)Amino Acid
FLDDAD
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 11/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Amino Acid Linearities by FLD on RRHT EclipsePlus C18, 3.0 x 50mm, 1.8µ, no ISs
0
200
400
600
800
1000
1200
0 20 40 60 80 100 120 140
pMoles on Column
A r e a C o u n t
s
ASP
GLU
SER
HIS
GLY
THR
ARG
ALA
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 12/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Amino Acid Linearities by FLD on RRHT EclipsePlus C18, 3.0 x 50mm, 1.8µ, no ISs
0
200
400
600
800
1000
1200
1400
0 20 40 60 80 100 120 140
pMoles on Column
A r e a C o u n t s
TYR
VAL
MET
PHE
ILE
LEU
LYS
PRO
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 13/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Reproducibility of 5.0 pMoles on column using an RRHTEclipse Plus C18, 2.1 x 50mm, 1.8µ, FLD, no ISs
min0 1 2 3 4 5 6 7
LU
0
20
40
60
80
100
120
140
160
1
24 6
8
9
10
11 1314 17
18 19
23
20
7
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 14/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Preparation of Low-Sensitivity Amino Acid StandardSolutions. Prepare the three low-sensitivity standards bymixing together stock solutions in the volumes shown.
1 mL 1 mL 1 mLFinal AA Solution with
EAA and 500 pMoles/µL ISTD
— — 900µLAdd 100 pMolesAA standard
— 900µL —Add 250 pMoles AA standard
900µL — —Add 1000 pMoles AA standard
100µL 100µL 100µLTake 100 µ L EAA-ISTD mix
10mL 10mL 10mLEAA-ISTD mix
5mL 5mL 5mLAdd 10 nMoles ISTD solution
5mL 5mL 5mLTake 5 mL diluted EAA mix
5mL 20mL 50mLDiluted EAA mix
― 15ml 45mlDilute with 0.1NHCl
5ml 5ml 5mlTake 5 mL 18 nMoles EAA
Concentration of Final AA Solutions
(pMoles/µL)
900 225 90
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 15/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Preparation of High-Sensitivity Amino Acid StandardSolutions. Prepare the three high-sensitivity standards bymixing together stock solutions in the volumes shown.
1 mL 1 mL 1 mLFinal AA Solution with
EAA and 50 pMoles/µL ISTD
— — 900µLAdd 10 pMoles AA standard
— 900µL —Add 25 pMoles AA standard 900µL — —Add 100 pMoles AA standard
100µL 100µL 100µLTake 100 µ L EAA-ISTD mix
10mL 10mL 10mLEAA-ISTD mix
5mL 5mL 5mLAdd 1.0 nMoles ISTD solution
5mL 5mL 5mLTake 5 mL diluted EAA mix
5mL 20mL 50mLDiluted EAA mix
― 15ml 45mlDilute with 0.1NHCl
5ml 5ml 5mlTake 5 mL 1.8 nMoles EAA
Concentration of Final AA Solutions
(pMoles/µL)
90 22.5 9
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 16/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Comparison of a variety of Beers available in theUSA using the 1200SL, DAD & I.S.
min1 2 3 4 5 60
mAU
0
20
40
60
80
100
120
140
English Beerbrewed for US Market
German Beer brewed for US market
Typical American Beer
American Beer brewed to German purity laws
900pMole/ul AAA std + 500pMole/ul I.S.1
2 3 4 5
6 89 10 11 13 14
15
1617 18 19
22 23
20
21
7
12
Column: RRHT Eclipse Plus C18, 4.6x50mm, 1.8µ
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 17/23
Group/Presentation Title
Agilent RestrictedMonth ##, 200X
Comparison of the Amino Acid Content of VariousBottled Beers
36.034.862.727.9Total =
10.2915.8834.848.65PROISISISISSAR
1.261.171.740.20HYP
0.900.080.320.30LYS1.750.551.711.02LEU0.940.340.970.54ILE
2.071.232.211.33PHE0.670.801.070.58TRP
ISISISISNVA
0.160.110.270.17MET2.831.933.351.92VAL0.050.080.100.08CYS-CYS
1.771.652.861.36TYR4.604.565.144.28ALA1.831.290.940.48ARG
0.200.740.340.30THR1.571.612.001.54GLY0.891.071.000.68HIS
0.330.380.760.67GLN0.260.120.400.45SER0.540.140.981.19ASN
1.980.800.931.07GLU1.150.260.731.06ASP
µMoles /mlµMoles /mlµMoles /mlµMoles /ml
English Beer brewed forUS market
German Beer brewed forUS market
American Beer brewed toGerman purity laws
Typical American BeerAmino Acid
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 18/23
Group/Presentation TitleAgilent Restricted
Month ##, 200X
Amino Acid Analysis on RRHT Eclipse Plus C18, 2.1, 3.0 or4.6 x 50mm, 1.8µ Column: Experimental Conditions
AAA on production 1200SL using Eclipse Plus-C18, 2.1, 3.0, or 4.6 x 50mm, 1.8uMobile phase A: 10mM Na2HPO4 – 10mM Na2B4O7, pH 8.2 – 0.5mM NaN3
5.6gm anhydrous Na2HPO4 + 15.2gm Na2B4O7· 10H2O in 4L water + 32mg NaN3
Adjust to ~pH 9 with 6ml concentrated HCl and then small drops until pH 8.2. Be cautious with strong acids!
Filter through 0.45µ regenerated cellulose membranes (Agilent P/N 3150-0576)
Stable for ~1.5 weeks at room temperature
Mobile phase B: ACN: MeOH: H2O 45:45:10 by volume
Injection diluent: 1ml Mobile phase A + 15µl concentrated H3PO4 in a 1 ml vial. Make this in 100ml batches.
Instrument config:
Pump: no mixer, no pulse dampener, bypass used (at 0.1min after inject command), compressibility settings used: A= 35, B= 80
Flow rate: 0.420ml/min for 2.1mm ID; 0.85ml/min for 3.0mmID 2.00ml/min for 4.6mm ID
Gradient Timetable: Time (min) %B0.0 2.0
1.0 2.0
7.0 57.0
7.1 100.0
8.4 100.0
8.6 2.0
Stop time 8.7
DAD: PW 0.01min; slit 4nm; Stop time 7min (adjust as needed) Cell = 5µl, 6mm flow path (Agilent P/N G1315-60025)
338, 10nm; Ref 390, 20nm
262, 16nm; Ref 324, 8nm
338, 10nm; Ref 390, 20nm230, 16nm; Ref 360,100nm
Timetable Signal C): 0.00 min 338, 10nm; Ref 390, 20nm
5.53 min 262, 16nm; Ref 324, 8nm (adjust as needed; 4.6mm ID transition at ~5.4min)
FLD: PW 0.01min, Stop time 7 min (adjust as needed), never use this detector before another due to fragility of flow cell
Ex 230nm; Em 450nm; Filter 295nm (Default filter)
Timetable Signal: 0.00 min Ex 230nm, Em 450nm; PMT Gain 9 (as needed)
5.53 min Ex 266nm, Em 305nm; PMT Gain 9 (as needed; 4.6mm ID transition at ~5.4min)
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 19/23
Group/Presentation TitleAgilent Restricted
Month ##, 200X
Amino Acid Analysis on RRHT Eclipse Plus C18, 2.1, 3.0 or4.6 x 50mm, 1.8µ Column: Conditions continued
TCC: used with low dispersion kit installed; T = 40°C for column side, 30°C for exit side. Low dispersion kitused on both sides.WPS: Def. vol set to 0.5ul, def speed used throughout injector program is 200ul/min
Injector program:1) Draw 2.5µl from Borate vial (Agilent P/N 5061-3339)2) Draw 0.5µl from Sample vial3) Mix 3µl in washport 5X4) Wait 0.2min
5) Draw 0.5µl from OPA vial (Agilent P/N 5061-3335)6) Mix 3.5µl in washport 6X7) Draw 0.4µl from FMOC vial (Agilent P/N 5061-3337)8) Mix in 3.9µl in washport 10X9) Draw 32µl from Diluent vial10) Mix 20µl in washport 8X11) Inject12) Wait 0.10 min13) Valve bypass
All tubing is 0.12mm ID throughout. Maximum sensitivity is obtained with 2.1mm columns. Toproperly integrate the first peak, set the integrator to detect negative peaks. If you wish to minimizethe degradants in the DAD chromatogram use new reagents and mobile phase. OPA and FMOC arenot stable left open to the atmosphere at room temperature. All modules are 1200SL whereavailable; the autosampler is a WPS. Typically use 54 position plate in front for reagents andsamples and 15 position plate in back for 6ml diluent vial. Gives enough for 24 hour sequence.
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 20/23
Group/Presentation TitleAgilent Restricted
Month ##, 200X
Conclusions: We can Squeeze More into Less!
1. Derivatization and Analysis are still totally Automated2. Cycle time more than cut in half (~13.5 min.)
3. Peak shapes of early eluters Asp and Glu muchnarrower4. Reproducibility of secondary AAs improved5. Linearity by linear regression is still almost 1.06. Average area reproducibility is below 2%
7. Scalability is greatly improved (2.1→
4.6mm id)8. Number of useable columns (12) and phases (2) isgreatly expanded
New State:
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 21/23
Group/Presentation TitleAgilent Restricted
Month ##, 200X
Bibliography
• Rainer Schuster and Alex Apfel, Hewlett-Packard App. Note, Pub.#5954-6257 (1986)
• Rainer Schuster, J. Chromatogr., 431, 271-284 (1988)• Herbert Godel, Petra Seitz, and Martin Verhoef, LC-GC International,
5(2), 44-49 (1992)• John W. Henderson, Robert D. Ricker, Brian A. Bidlingmeyer, and Cliff
Woodward, Agilent App. Note, Pub.# 5980-1193E (2000)• S. Moore and W.H. Stein, J. Biol. Chem., 192, 663 (1951)• M. Roth, Anal Chem, 43, 880-882 (1971)• S.B. Einarsson, B. Josefsson, and S. Lagerkvist, J. Chromatogr., 282,
609-618 (1983)• I. Betnér and P. Földi, LC-GC International, 2(3), 44-53 (1989)• B. Gustavsson and I. Betnér, J. Chromatogr., 507, 67-77 (1990)
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 22/23
Group/Presentation TitleAgilent Restricted
Month ##, 200X
Supplies list:ZORBAX Eclipse Plus-C18 HPLC Columns
Description Size Particle Agilent(mm) Size (µm) Part No.
Eclipse Plus-C18 4.6 x 50mm 1.8µm 959941-902
Eclipse Plus-C18 3.0 x 50mm 1.8µm 959941-302
Eclipse Plus-C18 2.1 x 50mm 1.8µm 959741-902
Derivatization Reagents
Description AgilentPart No.
Borate Buffer: 0.4 M in water, pH 10.2, 100mL 5061-3339
F MOC Rea ge nt, 2.5 mg/mL in ACN, 10 x 1 mL a mpoule s 5061-3337
OPA Reagent, 10mg/mL in 0.4M borate buffer and
3-mercaptoproprionic acid, 6 x 1mL ampoules 5061-3335
DTDPA Reagent for analysis of cysteine, 5g 5062-2479
Mobile Phase and Injection Diluent Components
Description Mfgr.'sManufacturer Mfgr.'sPart No.
Na2HPO4, Sodium Phosphate, Dibasic Sigma S 7907Na2B4O7·10H2O, Sodium Tetrborate Decahydrate Sigma S 9640NaN3, Sodium Azide Sigma S 2002H3PO4, ortho Phosphoric Acid Sigma 79617
Vials
Description AgilentPart No.
100 µL Conical insert with polymer feet, 100/pk 5181-1270Amber, wide-opening, write-on, screw-top vial, 2mL,100/pk 5182-0716Blue polypropylene cap, PTFE/silicone septum, 100/pk 5182-0721Clear glass screw cap vial, 6ml,16mm cap size, 100/pk 9301-1377Screw caps, 16mm, 100/pk 9301-1379PTFE/silicone septa, 16mm, 100/pk 9301-1378
StandardsDescription Agilent
Part No.
Amino Acid Standards in 0.1 M HCl, 10 x 1mL ampoules
1 nmol /ml 5061-3330250 pmol /ml 5061-3331100 pmol /ml 5061-3332
25 pmol /ml 5061-333310 pmol /ml 5061-3334
Supplemental Amino Acids:
Nva, Sar, Asn, Gln, Trp, Hyp, 1g each 5062-2478
5/9/2018 theanine 2 - slidepdf.com
http://slidepdf.com/reader/full/theanine-2 23/23
Group/Presentation TitleAgilent Restricted
Month ##, 200X
Availability of this talk
A new App note has just been published 2/23/2007:
“High-Speed Amino Acid Analysis (AAA) on 1.8µmReversed-Phase (RP) Columns”
Agilent Pub. # 5989-6297EN